Hepatitis Research and Treatment / 2011 / Article / Tab 2

Research Article

Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia

Table 2

Clinical and demographic characteristics of patients with positive serological markers for HBV and HCV.

CodeDiagnosisOriginAgeGenderAlcohol*Type of simpleSerological marker
SerumLiver tissueHBsAgAnti-HCV

UdeA-001CiColombia68F4NAYesNegPos
UdeA-002CiColombia59M4NAYesNegPos
UdeA-003CiColombia68M4NAYesNegPos
UdeA-004CiColombia47M4YesNAPosNeg
UdeA-006HCC + CiColombia48M4NAYesNegPos
UdeA-009CiColombia69M1YesNAPosNeg
UdeA-015HCC + CiColombia68F9NAYesNegPos
UdeA-024CiEl Salvador60M9NAYesPosNeg
UdeA-054CiVenezuela47M3YesYesPosNeg
UdeA-056HCC + CiColombia56F4YesNAPosNeg
UdeA-058HCC + CiColombia53M9YesNAPosNeg
UdeA-061CiColombia47F4YesNAPosNeg
UdeA-065CiColombia58F1NAYesNegPos
UdeA-069HCCColombia64F4NAYesNegPos
UdeA-070CiColombia34M4NAYesNegPos
UdeA-072CiIsrael49M3YesYesPosNeg
UdeA-077CiColombia57M1YesNAPosNeg
UdeA-083HCC + CiColombia67F4YesYesPosNeg
UdeA-087CiColombia48M2YesNAPosNeg
UdeA-089HCC + CiColombia47F4YesYesPosNeg
UdeA-099CiColombia56M4YesNAPosNeg
UdeA-101CiColombia74F4YesNAPosNeg
UdeA-124HCC + CiColombia57M2YesNAPosNeg

ci: Cirrhosis, HCC: hepatocellular carcinoma, M: male, F: female, *Alcohol intake: for male/(female) 1: >80 g/day (40g/day); 2: 50–80 g/day (20–40 g/day); 3: <50 g/day (20 g/day) 4: no intake; 9: no data; Yes: available; NA: nonavailable; Yes: HBV/HCV-positive sample by molecular analysis; Pos: positive serological result;Neg: negative serological result.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.